Self-reported dyspnoea and shortness of breathing deterioration in long-term survivors after segmentectomy or lobectomy for early-stage lung cancer

Eur J Cardiothorac Surg. 2024 May 3;65(5):ezae200. doi: 10.1093/ejcts/ezae200.

Abstract

Objectives: The aim of this study was to assess the self-reported current dyspnoea and perioperative changes of dyspnoea in long-term survivors after minimally invasive segmentectomy or lobectomy for early-stage lung cancer.

Methods: Cross-sectional telephonic survey of patients alive and disease-free as of March 2023, with pathologic stage IA1-2, non-small-cell lung cancer, assessed 1-5 years after minimally invasive segmentectomy or lobectomy (performed from January 2018 to January 2022). Current dyspnoea level: Baseline Dyspnoea Index score <10. Perioperative changes of dyspnoea were assessed using the Transition Dyspnoea Index. A negative Transition Dyspnoea Index focal score indicates perioperative deterioration in dyspnoea. Mixed effect models were used to examine demographic, medical and health-related correlates of current dyspnoea and changes in dyspnoea level.

Results: A total of 152 of 236 eligible patients consented or were available to respond to the telephonic interview(67% response rate): 90 lobectomies and 62 segmentectomies. The Baseline Dyspnoea Index score was lower (greater dyspnoea) in lobectomy patients (median 7, interquartile range 6-10) compared to segmentectomy (median 9, interquartile range 6-11), P = 0.034. 70% of lobectomy patients declared to have a current dyspnoea vs 53% after segmentectomy, P = 0.035. 82% of patients after lobectomy reported a perioperative deterioration in their dyspnoea compared to 57% after segmentectomy, P = 0.002. Mixed effect logistic regression analysis adjusting for patient-related factors and time elapsed from operation showed that segmentectomy was associated with a reduced risk of perioperative dyspnoea deterioration (as opposed to lobectomy) (Odds ratio (OR) 0.31, P = 0.004).

Conclusions: Our findings may be valuable to inform the shared decision-making process by complementing objective data on perioperative changes of pulmonary function.

Keywords: Dyspnoea; Lobectomy; Non-small-cell lung cancer; Patient-reported outcomes; Quality of life; Segmentectomy.

MeSH terms

  • Aged
  • Carcinoma, Non-Small-Cell Lung* / surgery
  • Cross-Sectional Studies
  • Dyspnea* / etiology
  • Female
  • Humans
  • Lung Neoplasms* / surgery
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Pneumonectomy* / adverse effects
  • Pneumonectomy* / methods
  • Postoperative Complications / epidemiology
  • Postoperative Complications / etiology
  • Self Report*